Literature DB >> 20029213

Timing of birth and risk of multiple sclerosis in the Scottish population.

Hannah K Bayes1, Christopher J Weir, Colin O'Leary.   

Abstract

Development of multiple sclerosis (MS) is believed to result from interplay of genes and environmental factors, which may be anticipated to act in a seasonal manner. Scotland has the highest prevalence of MS in the world. We aimed to determine if risk of multiple sclerosis is associated with season of birth in the Scottish population. Data for MS patients within the West of Scotland (n = 1,309) was obtained. Birth rates of MS patients were compared with national (n = 6,198,352) and regional (n = 664,447) controls. Excess MS births occur in the spring months, with 22% more than expected (401 observed vs. 328 expected, p < 0.0001). Peak month in both sexes was April. Fewer MS births occurred in autumn, with 16% fewer births compared with regional controls (275 observed vs. 328 expected, p = 0.01). Our study, the largest in the Scottish population, demonstrates season of birth and risk of MS are associated. Elucidating potential environmental factor(s) accounting for such an association remains a challenge. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 20029213     DOI: 10.1159/000268163

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  13 in total

1.  Confirmation of association between multiple sclerosis and CYP27B1.

Authors:  Emilie Sundqvist; Maria Bäärnhielm; Lars Alfredsson; Jan Hillert; Tomas Olsson; Ingrid Kockum
Journal:  Eur J Hum Genet       Date:  2010-07-21       Impact factor: 4.246

Review 2.  Influence of photoperiod on hormones, behavior, and immune function.

Authors:  James C Walton; Zachary M Weil; Randy J Nelson
Journal:  Front Neuroendocrinol       Date:  2010-12-13       Impact factor: 8.606

3.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 4.  Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment.

Authors:  Jimmy L Huynh; Patrizia Casaccia
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

5.  Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.

Authors:  Nete Munk Nielsen; Kassandra L Munger; Nils Koch-Henriksen; David M Hougaard; Melinda Magyari; Kristian T Jørgensen; Marika Lundqvist; Jacob Simonsen; Tine Jess; Arieh Cohen; Egon Stenager; Alberto Ascherio
Journal:  Neurology       Date:  2016-11-30       Impact factor: 9.910

6.  Maternal and perinatal factors associated with hospitalised infectious mononucleosis in children, adolescents and young adults: record linkage study.

Authors:  Imran Mahmud; Omar A Abdel-Mannan; Clare J Wotton; Michael J Goldacre
Journal:  BMC Infect Dis       Date:  2011-02-28       Impact factor: 3.090

7.  Epidemiology of multiple sclerosis in Qom: Demographic study in Iran.

Authors:  Saeed Rezaali; Ahad Khalilnezhad; Abdorreza Naser Moghadasi; Samira Chaibakhsh; Mohammad Ali Sahraian
Journal:  Iran J Neurol       Date:  2013

Review 8.  Confounding in association studies: month of birth and multiple sclerosis.

Authors:  Barnaby Fiddes; James Wason; Stephen Sawcer
Journal:  J Neurol       Date:  2014-01-12       Impact factor: 4.849

9.  Prenatal vitamin D deficiency induces an early and more severe experimental autoimmune encephalomyelitis in the second generation.

Authors:  Diana Andrea Fernandes de Abreu; Véréna Landel; Adrian G Barnett; John McGrath; Darryl Eyles; Francois Feron
Journal:  Int J Mol Sci       Date:  2012-08-30       Impact factor: 6.208

10.  Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS).

Authors:  Omid Mirmosayyeb; Mahdi Barzegar; Alireza Afshari-Safavi; Nasim Nehzat; Afshin Heidari; Parisa Emami; Vahid Shaygannejad
Journal:  Mult Scler Int       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.